Skip to main content
. 2014 Dec 31;5(24):12593–12606. doi: 10.18632/oncotarget.2518

Figure 6. TGFB1I1 promoted tumor progression in vivo.

Figure 6

(A and B) Tumor volume with the TGFB1I1 shRNA was significantly smaller than did control mice. N (control)=6 and N (TGFB1I1shRNA)=4 (C) Immunohistochemical staining for the 2 groups of mice, showing decreased vimentin, β-catenin and MMP-2 in mice injected with TGFB1I1 shRNA.